BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//UCLA - ECPv5.14.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:UCLA
X-ORIGINAL-URL:https://www.chemistry.ucla.edu
X-WR-CALDESC:Events for UCLA
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20210204T160000
DTEND;TZID=America/Los_Angeles:20210204T160000
DTSTAMP:20260618T154749
CREATED:20210114T004759Z
LAST-MODIFIED:20210114T004759Z
UID:13418-1612454400-1612454400@www.chemistry.ucla.edu
SUMMARY:“The Journey of Remdesivir from Respiratory Syncytial Virus to COVID-19”
DESCRIPTION:Abstract: SARS-CoV2\, the causative agent of the COVID-19 pandemic\, is an RNA virus that has efficient human to human transmission and carries significant morbidity and mortality for vulnerable patient populations. Remdesivir (Veklury®) is a broad-spectrum inhibitor of RNA viruses and the first agent to be approved for the treatment of COVID-19. \nThe seminar will introduce the concept of targeting RNA viruses through inhibition of the viral polymerase by nucleoside analogs\, and then focus on the early discovery of the nucleotide prodrug\, remdesivir for respiratory syncytial virus. Topics discussed will include structure-activity relationships\, prodrug design\, mechanism of action\, and pharmacokinetics. The identification of the broad-spectrum activity of remdesivir toward RNA viruses including Ebola and SARS-CoV2 paved the next stage in the journey of remdesivir. Details on the synthesis and early route optimization to support the development of remdesivir for Ebola will be highlighted. Finally\, a summary of the preclinical data evaluating remdesivir toward SARS-CoV2\, and the clinical data that supported its regulatory approval for COVID-19\, will conclude the talk.
URL:https://www.chemistry.ucla.edu/seminars/journey-remdesivir-respiratory-syncytial-virus-covid-19/
CATEGORIES:Organic Colloquium,Seminars
END:VEVENT
END:VCALENDAR